Covid-19 roundup: Germany pours nearly $450M into BioNTech; AstraZeneca still hasn't resumed its vaccine trial in the US
Pfizer CEO Albert Bourla has made a point since the pandemic’s early days of rejecting US assistance for their Covid-19 vaccine, separating them from the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
